Omega Healthcare Investors (OHI)
Market Price (3/7/2026): $47.6 | Market Cap: $14.1 BilSector: Real Estate | Industry: Health Care REITs
Omega Healthcare Investors (OHI)
Market Price (3/7/2026): $47.6Market Cap: $14.1 BilSector: Real EstateIndustry: Health Care REITs
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.7%, Dividend Yield is 5.5%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 5.4%, FCF Yield is 6.2% | Trading close to highsDist 52W High is -1.2%, Dist 3Y High is -1.2% | Expensive valuation multiplesP/SPrice/Sales ratio is 12x |
| Strong revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is 13% | Key risksOHI key risks include [1] significant tenant concentration and financial distress, Show more. | |
| Attractive operating marginsOp Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 63% | ||
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 74%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 74% | ||
| Low stock price volatilityVol 12M is 21% | ||
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease. Themes include Geriatric Care. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.7%, Dividend Yield is 5.5%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 5.4%, FCF Yield is 6.2% |
| Strong revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is 13% |
| Attractive operating marginsOp Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 63% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 74%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 74% |
| Low stock price volatilityVol 12M is 21% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease. Themes include Geriatric Care. |
| Trading close to highsDist 52W High is -1.2%, Dist 3Y High is -1.2% |
| Expensive valuation multiplesP/SPrice/Sales ratio is 12x |
| Key risksOHI key risks include [1] significant tenant concentration and financial distress, Show more. |
Qualitative Assessment
AI Analysis | Feedback
1. Omega Healthcare Investors significantly surpassed Q4 2025 earnings expectations, reporting adjusted Funds From Operations (FFO) of $0.80 per share, which beat the Zacks consensus estimate of $0.79. The company also posted robust quarterly revenue of $319.2 million and increased net income to $172 million from $116 million in Q4 2024. Furthermore, OHI provided strong 2026 adjusted FFO guidance of $3.15 to $3.25 per share, indicating continued financial strength and positive outlook.
2. The company substantially strengthened its financial position through significant debt reduction, repaying $1.7 billion in debt during 2025, which brought its leverage to company lows. This financial discipline, coupled with a well-laddered, mostly fixed-rate debt structure and a new $2.3 billion credit facility, positions Omega Healthcare Investors for future high-yield acquisitions and portfolio expansion.
Show more
Stock Movement Drivers
Fundamental Drivers
The 5.4% change in OHI stock from 11/30/2025 to 3/6/2026 was primarily driven by a 5.9% change in the company's Net Income Margin (%).| (LTM values as of) | 11302025 | 3062026 | Change |
|---|---|---|---|
| Stock Price ($) | 45.24 | 47.69 | 5.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,150 | 1,190 | 3.5% |
| Net Income Margin (%) | 46.8% | 49.6% | 5.9% |
| P/E Multiple | 24.8 | 24.0 | -3.6% |
| Shares Outstanding (Mil) | 296 | 296 | -0.2% |
| Cumulative Contribution | 5.4% |
Market Drivers
11/30/2025 to 3/6/2026| Return | Correlation | |
|---|---|---|
| OHI | 5.4% | |
| Market (SPY) | -1.6% | -37.9% |
| Sector (XLRE) | 2.9% | 10.4% |
Fundamental Drivers
The 15.6% change in OHI stock from 8/31/2025 to 3/6/2026 was primarily driven by a 17.4% change in the company's Net Income Margin (%).| (LTM values as of) | 8312025 | 3062026 | Change |
|---|---|---|---|
| Stock Price ($) | 41.27 | 47.69 | 15.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,115 | 1,190 | 6.8% |
| Net Income Margin (%) | 42.2% | 49.6% | 17.4% |
| P/E Multiple | 25.5 | 24.0 | -6.2% |
| Shares Outstanding (Mil) | 291 | 296 | -1.8% |
| Cumulative Contribution | 15.6% |
Market Drivers
8/31/2025 to 3/6/2026| Return | Correlation | |
|---|---|---|
| OHI | 15.6% | |
| Market (SPY) | 4.5% | -16.9% |
| Sector (XLRE) | 2.1% | 28.0% |
Fundamental Drivers
The 38.3% change in OHI stock from 2/28/2025 to 3/6/2026 was primarily driven by a 28.3% change in the company's Net Income Margin (%).| (LTM values as of) | 2282025 | 3062026 | Change |
|---|---|---|---|
| Stock Price ($) | 34.48 | 47.69 | 38.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,051 | 1,190 | 13.2% |
| Net Income Margin (%) | 38.6% | 49.6% | 28.3% |
| P/E Multiple | 23.3 | 24.0 | 2.9% |
| Shares Outstanding (Mil) | 274 | 296 | -7.5% |
| Cumulative Contribution | 38.3% |
Market Drivers
2/28/2025 to 3/6/2026| Return | Correlation | |
|---|---|---|
| OHI | 38.3% | |
| Market (SPY) | 14.2% | 9.4% |
| Sector (XLRE) | 1.7% | 42.3% |
Fundamental Drivers
The 123.9% change in OHI stock from 2/28/2023 to 3/6/2026 was primarily driven by a 104.4% change in the company's P/E Multiple.| (LTM values as of) | 2282023 | 3062026 | Change |
|---|---|---|---|
| Stock Price ($) | 21.30 | 47.69 | 123.9% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 878 | 1,190 | 35.5% |
| Net Income Margin (%) | 48.6% | 49.6% | 2.0% |
| P/E Multiple | 11.7 | 24.0 | 104.4% |
| Shares Outstanding (Mil) | 235 | 296 | -20.8% |
| Cumulative Contribution | 123.9% |
Market Drivers
2/28/2023 to 3/6/2026| Return | Correlation | |
|---|---|---|
| OHI | 123.9% | |
| Market (SPY) | 76.0% | 15.7% |
| Sector (XLRE) | 23.2% | 47.5% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| OHI Return | -12% | 3% | 20% | 34% | 26% | 8% | 97% |
| Peers Return | 43% | -19% | 20% | 6% | 9% | 8% | 73% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -0% | 82% |
Monthly Win Rates [3] | |||||||
| OHI Win Rate | 33% | 50% | 67% | 67% | 50% | 33% | |
| Peers Win Rate | 75% | 35% | 60% | 53% | 57% | 60% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 33% | |
Max Drawdowns [4] | |||||||
| OHI Max Drawdown | -19% | -11% | -6% | -7% | -4% | -3% | |
| Peers Max Drawdown | -9% | -32% | -8% | -14% | -18% | -2% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: EGP, BRX, FR, COLD, WELL.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 3/6/2026 (YTD)
How Low Can It Go
| Event | OHI | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -35.8% | -25.4% |
| % Gain to Breakeven | 55.8% | 34.1% |
| Time to Breakeven | 848 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -66.9% | -33.9% |
| % Gain to Breakeven | 202.3% | 51.3% |
| Time to Breakeven | 2,071 days | 148 days |
| 2018 Correction | ||
| % Loss | -26.8% | -19.8% |
| % Gain to Breakeven | 36.7% | 24.7% |
| Time to Breakeven | 272 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -45.5% | -56.8% |
| % Gain to Breakeven | 83.4% | 131.3% |
| Time to Breakeven | 402 days | 1,480 days |
Compare to EGP, BRX, FR, COLD, WELL
In The Past
Omega Healthcare Investors's stock fell -35.8% during the 2022 Inflation Shock from a high on 4/7/2021. A -35.8% loss requires a 55.8% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Omega Healthcare Investors (OHI)
AI Analysis | Feedback
Here are 1-3 brief analogies for Omega Healthcare Investors (OHI):
- American Tower for healthcare properties.
- Prologis for nursing homes and assisted living facilities.
AI Analysis | Feedback
- Real Estate Leasing: Omega Healthcare Investors acquires and leases out a portfolio of healthcare facilities, primarily skilled nursing and assisted living facilities, to third-party operators under long-term, triple-net lease agreements.
- Mortgage and Other Debt Financing: The company provides mortgage loans and other forms of debt financing to healthcare operators, often in conjunction with or as an alternative to direct property ownership.
AI Analysis | Feedback
Omega Healthcare Investors (OHI) is a real estate investment trust (REIT) that invests in healthcare facilities, primarily skilled nursing and assisted living facilities. As such, its primary "customers" are the operating companies that lease and manage these facilities.
Based on their 2023 Annual Report (10-K), Omega Healthcare Investors' major customers (operators) and their approximate percentage of annualized contractual rent and mortgage interest revenue as of December 31, 2023, are:
- Maplewood Senior Living (Private Company) - 12.1%
- Guardian Healthcare (Private Company) - 9.1%
- Agemo Group (Private Company) - 8.8%
- Laurel Health Care Company (Private Company) - 7.1%
- CommuniCare Health Services (Private Company) - 5.9%
- Revera Health Services (Private Company) - 5.9%
AI Analysis | Feedback
- PNC Financial Services Group, Inc. (Symbol: PNC)
- Deloitte & Touche LLP
AI Analysis | Feedback
C. Taylor Pickett Chief Executive OfficerMr. Pickett has served as Chief Executive Officer of Omega Healthcare Investors since 2001 and as a Director since May 2002. Prior to joining Omega, he was a member of the senior management team of Integrated Health Services, Inc. (IHS) from 1993 to June 2001, where he served most recently as Executive Vice President and Chief Financial Officer. Before his time at IHS, Mr. Pickett held various positions at PHH Corporation and KPMG Peat Marwick. He also serves as a member of the board of trustees for COPT Defense Properties (NYSE:CDP).
Robert O. Stephenson Chief Financial OfficerMr. Stephenson has served as Chief Financial Officer of Omega Healthcare Investors since August 2001. From 1996 to July 2001, he was the Senior Vice President and Treasurer of Integrated Health Services, Inc. Prior to joining Integrated Health Services, Inc., Mr. Stephenson held various positions at CSX Intermodal, Inc., Martin Marietta Corporation, and Electronic Data Systems. He also serves on the Board of the University of Maryland Medical Center (UMMC) and was appointed to the Board of Directors for Plymouth Industrial REIT (NYSE:PLYM) in March 2025.
Matthew P. Gourmand PresidentMr. Gourmand was appointed President in January 2025. He previously served as Senior Vice President of Corporate Strategy & Investor Relations at Omega Healthcare Investors since October 2017. Before joining Omega, Mr. Gourmand spent 10 years as an equity portfolio manager at Millennium Partners and Stevens Capital Management. His prior experience also includes three years as an equity research analyst at UBS and six years in the audit department of Deloitte, where he qualified as a Chartered Accountant and a Certified Public Accountant.
Vikas Gupta Chief Investment OfficerMr. Gupta was appointed Chief Investment Officer in January 2025. He joined Omega Healthcare Investors in July 2011 and most recently served as Senior Vice President of Acquisitions & Development as of April 2015. From 2003 to July 2011, Mr. Gupta held various roles at CapitalSource Finance, where he oversaw a portfolio of healthcare assets. He currently serves on the Board of Directors for the Foundation for International Medical Relief of Children (“FIMRC”) and the National Investment Center for Seniors Housing & Care (“NIC”), and is on the Executive Board for the American Seniors Housing Association (“ASHA”).
Neal A. Ballew Chief Accounting OfficerMr. Ballew joined Omega Healthcare Investors in August 2020 as Chief Accounting Officer, overseeing the accounting and financial reporting functions. Before his tenure at Omega, he spent 10 years in EY's real estate and hospitality audit practice, most recently as a senior manager within EY's professional practice group.
AI Analysis | Feedback
Here are the key risks to Omega Healthcare Investors (OHI):- Tenant Financial Health and Bankruptcy Risk: Omega Healthcare Investors' business model relies heavily on its tenants, primarily skilled nursing and senior housing operators, consistently paying rent. The financial health of these operators is a critical factor, and any significant financial difficulties, defaults, or bankruptcies among them can directly impact OHI's revenue and profitability. Several tenants have faced issues, including past bankruptcies (e.g., Genesis) and ongoing investigations (e.g., PACS Group, OHI's fifth-largest tenant, which is under investigation for billing practices and has not filed current financials). As of mid-2025, approximately 4.3% of OHI's portfolio rent comes from facilities with an EBITDAR (Earnings Before Interest, Taxes, Depreciation, Amortization, and Rent) coverage below 1.0x, indicating a risk of future non-payment. The concentration of revenue from key operators also poses a risk, as challenges faced by a major tenant could lead to substantial cash flow vulnerability.
- Regulatory Risks and Government Reimbursement Changes: The healthcare sector is highly regulated, and Omega Healthcare Investors' tenants are significantly dependent on government programs such as Medicare and Medicaid for the bulk of their revenue. Any changes in government policies, reimbursement rates, or stricter regulations can negatively affect the financial performance of these healthcare operators, thereby impacting their ability to meet rent obligations to OHI. The threat of potential funding cuts in Medicare and Medicaid is a constant concern for the industry.
- Interest Rate Sensitivity: As a real estate investment trust (REIT), Omega Healthcare Investors is sensitive to fluctuations in interest rates. Elevated interest rates increase OHI's cost of capital when issuing new debt, which can compress the spread between their cost of capital and the yield on their investments. Rising interest rates can also negatively impact the profit models of their operators, potentially leading to deferred or partial rent payments, as observed in previous periods. The company also utilizes debt to fund its investments, with a significant amount of long-term debt on its balance sheet, making it susceptible to higher capital costs if rates increase.
AI Analysis | Feedback
The accelerating shift towards home-based healthcare and "aging in place" models, driven by advancements in remote monitoring technologies, telehealth, and evolving payer preferences. This trend makes it increasingly feasible for individuals requiring post-acute care or long-term support to receive services in their homes, thereby reducing the demand for the skilled nursing and assisted living facilities that constitute Omega Healthcare Investors' primary asset base. This structural change in care delivery directly threatens the occupancy rates and long-term viability of traditional institutional care settings.
AI Analysis | Feedback
Omega Healthcare Investors (OHI) primarily invests in and provides financing for skilled nursing facilities (SNFs) and assisted living facilities (ALFs). The addressable markets for these services are substantial within the United States.
U.S. Skilled Nursing Facility Market
The U.S. skilled nursing facility market was valued at approximately USD 180.95 billion in 2023 and is projected to reach around USD 253.77 billion by 2033, demonstrating a compound annual growth rate (CAGR) of 3.44% during this forecast period. Other estimates place the market size at USD 199.72 billion in 2024, with an expected growth to USD 290.02 billion by 2033 at a CAGR of 4.39%. Further data indicates the market was valued at USD 161.9 billion in 2024 and is anticipated to be USD 167.5 billion in 2025. The U.S. skilled nursing facility market size was also evaluated at USD 119.75 billion in 2024 and is predicted to be worth around USD 287.10 billion by 2034, rising at a CAGR of 9.14% from 2025 to 2034.
U.S. Assisted Living Facility Market
The U.S. assisted living market was valued at USD 67.7 billion in 2024 and is projected to grow to approximately USD 108.2 billion by 2034, with a CAGR of 4.8% from 2025 to 2034. Another assessment estimated the market at USD 44.38 billion in 2024, with an expectation to reach USD 93.54 billion by 2033, growing at a CAGR of 8.69%. Additionally, the U.S. assisted living facility market size is valued at USD 103.5 billion in 2024 and is predicted to reach USD 182.3 billion by 2034, at a 5.9% CAGR during the forecast period. The broader U.S. senior living market, which includes assisted living, reached approximately USD 111.20 billion in 2024 and is projected to reach around USD 201.03 billion by 2034, growing at a CAGR of 6.10% between 2025 and 2034.
AI Analysis | Feedback
Omega Healthcare Investors (OHI) is expected to drive future revenue growth over the next 2-3 years through several key strategies: * New Investments and Acquisitions: Omega Healthcare Investors consistently engages in new investments and acquisitions of healthcare facilities, both in the United States and the United Kingdom. The company completed $834 million in new investments year-to-date in 2024, and $423 million in new investments through April 2025. By October 2025, Omega Healthcare Investors had made over $978 million in new investments, with more than 87% being real estate investments added to its balance sheet. This ongoing strategy of acquiring additional properties and making real estate loans directly contributes to an expanding revenue base. * Favorable Demographic Trends: The increasing population of individuals aged 65 and older, coupled with a rise in chronic health conditions, is driving greater demand for the types of healthcare facilities in which OHI invests. This demographic tailwind is anticipated to boost occupancy rates and strengthen operator coverage, thereby enhancing Omega's rent collection and earnings visibility. * Improved Occupancy and Operator Financial Health: Underlying demographic strength and recent legislative actions are contributing to increased demand and occupancy levels across OHI's portfolio. This is reflected in improved operator coverage ratios and stronger tenant rent collections. As of Q3 2025, occupancy and coverage metrics continued to improve, with Ebidar coverage reaching its highest level in 12 years. * Strategic Investments in Healthcare Technology: Omega Healthcare Investors has demonstrated a commitment to innovation through strategic investments, such as its stake in MedaSync, an AI-driven reimbursement software provider. This type of investment aims to help skilled nursing operators streamline reimbursement processes, which can indirectly support operator coverage and improve rent collection, contributing to stable and rising rental income for OHI. * Stabilized Reimbursement and Regulatory Environment: Recent legislative measures, including delays in staffing mandates, have helped to stabilize reimbursement outlooks and reduce regulatory risks within the healthcare industry. These changes are expected to foster more predictable tenant rent collections and enhance overall portfolio performance in the near term.AI Analysis | Feedback
Share Repurchases
- Omega Healthcare Investors authorized a $500 million share repurchase program in January 2022, which was scheduled to expire in March 2025.
- The company did not repurchase any shares under this program during 2024 or through the first nine months of 2025.
Share Issuance
- In Q1 2025, Omega issued 7 million shares of equity, generating gross proceeds of $264 million.
- The company issued 2 million common shares in Q3 2025 for gross proceeds of $89 million.
- In November 2025, Omega terminated its prior at-the-market (ATM) equity offering sales agreement and entered into a new one, authorizing the sale of common stock not to exceed an aggregate gross sales price of $2 billion.
Outbound Investments
- Year-to-date through Q3 2025, Omega completed approximately $978 million in new investments.
- In Q2 2025, the company acquired a 45-property portfolio of care homes in Scotland and Jersey for $344 million.
- In October 2025, Omega invested $222 million to acquire a 49% equity interest in a real estate joint venture owning 64 healthcare facilities with Sabre Healthcare, and also made a 9.9% equity investment in Sabre's operating company.
Capital Expenditures
- Omega Healthcare Investors invested $85.7 million in construction in progress and capital improvement programs during the nine months ended September 30, 2025.
- The company reported $34 million in capital expenditures during Q1 2025.
- During Q3 2025, an additional $24 million in capital expenditures was noted, separate from new investments.
Latest Trefis Analyses
Trade Ideas
Select ideas related to OHI.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 02272026 | KRC | Kilroy Realty | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 02202026 | AAT | American Assets Trust | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | -0.2% | -0.2% | -1.5% |
| 12122025 | LINE | Lineage | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | 11.7% | 11.7% | -7.3% |
| 11302025 | OHI | Omega Healthcare Investors | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 6.7% | 6.7% | -6.0% |
| 10312025 | ADC | Agree Realty | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | 11.8% | 11.8% | -2.8% |
| 09302020 | OHI | Omega Healthcare Investors | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 27.5% | 8.0% | -2.7% |
| 03312020 | OHI | Omega Healthcare Investors | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 17.1% | 50.4% | -9.2% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 53.77 |
| Mkt Cap | 9.6 |
| Rev LTM | 1,281 |
| Op Inc LTM | 331 |
| FCF LTM | 566 |
| FCF 3Y Avg | 517 |
| CFO LTM | 566 |
| CFO 3Y Avg | 517 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 10.6% |
| Rev Chg 3Y Avg | 10.6% |
| Rev Chg Q | 11.0% |
| QoQ Delta Rev Chg LTM | 2.6% |
| Op Mgn LTM | 38.3% |
| Op Mgn 3Y Avg | 38.1% |
| QoQ Delta Op Mgn LTM | 0.1% |
| CFO/Rev LTM | 55.5% |
| CFO/Rev 3Y Avg | 51.5% |
| FCF/Rev LTM | 55.5% |
| FCF/Rev 3Y Avg | 51.5% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 9.6 |
| P/S | 11.4 |
| P/EBIT | 29.5 |
| P/E | 28.0 |
| P/CFO | 16.6 |
| Total Yield | 5.8% |
| Dividend Yield | 3.4% |
| FCF Yield 3Y Avg | 5.0% |
| D/E | 0.3 |
| Net D/E | 0.3 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 5.6% |
| 3M Rtn | 5.7% |
| 6M Rtn | 13.9% |
| 12M Rtn | 12.5% |
| 3Y Rtn | 40.4% |
| 1M Excs Rtn | 7.7% |
| 3M Excs Rtn | 8.5% |
| 6M Excs Rtn | 10.8% |
| 12M Excs Rtn | -4.6% |
| 3Y Excs Rtn | -30.1% |
Price Behavior
| Market Price | $47.69 | |
| Market Cap ($ Bil) | 14.1 | |
| First Trading Date | 08/07/1992 | |
| Distance from 52W High | -1.2% | |
| 50 Days | 200 Days | |
| DMA Price | $44.95 | $40.79 |
| DMA Trend | up | up |
| Distance from DMA | 6.1% | 16.9% |
| 3M | 1YR | |
| Volatility | 21.4% | 20.1% |
| Downside Capture | -93.29 | -28.32 |
| Upside Capture | -67.50 | 12.11 |
| Correlation (SPY) | -36.4% | 10.8% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.95 | -0.83 | -0.80 | -0.31 | 0.10 | 0.22 |
| Up Beta | -0.42 | -0.71 | -0.75 | -0.14 | 0.29 | 0.26 |
| Down Beta | -0.87 | -0.62 | -0.66 | -0.29 | 0.07 | 0.20 |
| Up Capture | -29% | -50% | -58% | -7% | 8% | 11% |
| Bmk +ve Days | 9 | 20 | 31 | 70 | 142 | 431 |
| Stock +ve Days | 15 | 26 | 35 | 71 | 140 | 410 |
| Down Capture | -222% | -156% | -129% | -79% | -41% | 15% |
| Bmk -ve Days | 12 | 21 | 30 | 54 | 109 | 320 |
| Stock -ve Days | 6 | 15 | 25 | 52 | 106 | 334 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with OHI | |
|---|---|---|---|---|
| OHI | 35.9% | 20.5% | 1.38 | - |
| Sector ETF (XLRE) | 1.1% | 16.5% | -0.11 | 41.9% |
| Equity (SPY) | 16.4% | 19.2% | 0.66 | 10.2% |
| Gold (GLD) | 77.1% | 26.1% | 2.17 | -0.8% |
| Commodities (DBC) | 19.6% | 17.1% | 0.89 | 3.1% |
| Real Estate (VNQ) | 3.1% | 16.6% | 0.01 | 42.6% |
| Bitcoin (BTCUSD) | -21.4% | 45.5% | -0.39 | -16.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with OHI | |
|---|---|---|---|---|
| OHI | 13.5% | 24.3% | 0.50 | - |
| Sector ETF (XLRE) | 6.1% | 19.0% | 0.22 | 49.1% |
| Equity (SPY) | 13.0% | 17.0% | 0.60 | 28.7% |
| Gold (GLD) | 24.2% | 17.2% | 1.14 | 6.5% |
| Commodities (DBC) | 11.9% | 19.0% | 0.51 | 5.7% |
| Real Estate (VNQ) | 5.0% | 18.8% | 0.17 | 52.0% |
| Bitcoin (BTCUSD) | 7.5% | 56.8% | 0.35 | 7.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with OHI | |
|---|---|---|---|---|
| OHI | 12.7% | 34.3% | 0.44 | - |
| Sector ETF (XLRE) | 7.4% | 20.4% | 0.32 | 55.6% |
| Equity (SPY) | 15.0% | 17.9% | 0.72 | 39.1% |
| Gold (GLD) | 15.1% | 15.6% | 0.80 | 5.8% |
| Commodities (DBC) | 9.0% | 17.6% | 0.43 | 17.4% |
| Real Estate (VNQ) | 6.1% | 20.7% | 0.26 | 61.1% |
| Bitcoin (BTCUSD) | 66.7% | 66.8% | 1.06 | 13.0% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/4/2026 | 6.1% | 8.9% | 11.0% |
| 10/30/2025 | 5.4% | 8.7% | 17.3% |
| 7/31/2025 | 2.7% | 4.9% | 11.3% |
| 5/1/2025 | -4.0% | -6.1% | -2.1% |
| 2/5/2025 | -0.7% | -5.1% | -2.0% |
| 10/30/2024 | -0.1% | -5.4% | -2.9% |
| 8/1/2024 | 4.3% | 3.3% | 9.7% |
| 5/2/2024 | 0.2% | -1.7% | 3.3% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 13 | 12 | 13 |
| # Negative | 11 | 12 | 11 |
| Median Positive | 4.1% | 4.9% | 11.0% |
| Median Negative | -2.1% | -4.0% | -2.9% |
| Max Positive | 14.7% | 11.5% | 21.3% |
| Max Negative | -6.6% | -8.4% | -6.9% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 12/31/2025 | 02/09/2026 | 10-K |
| 09/30/2025 | 10/31/2025 | 10-Q |
| 06/30/2025 | 08/01/2025 | 10-Q |
| 03/31/2025 | 05/02/2025 | 10-Q |
| 12/31/2024 | 02/13/2025 | 10-K |
| 09/30/2024 | 10/31/2024 | 10-Q |
| 06/30/2024 | 08/02/2024 | 10-Q |
| 03/31/2024 | 05/03/2024 | 10-Q |
| 12/31/2023 | 02/12/2024 | 10-K |
| 09/30/2023 | 11/03/2023 | 10-Q |
| 06/30/2023 | 08/03/2023 | 10-Q |
| 03/31/2023 | 05/03/2023 | 10-Q |
| 12/31/2022 | 02/14/2023 | 10-K |
| 09/30/2022 | 11/03/2022 | 10-Q |
| 06/30/2022 | 08/02/2022 | 10-Q |
| 03/31/2022 | 05/03/2022 | 10-Q |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Gupta, Vikas | Chief Investment Officer | Direct | Buy | 11062025 | 42.97 | 11,500 | 494,118 | 591,782 | Form |
| 2 | Pickett, C Taylor | CHIEF EXECUTIVE OFFICER | See Footnote | Buy | 11062025 | 43.14 | 20,000 | 862,856 | 862,856 | Form |
| 3 | Egbuonu-Davis, Lisa | Direct | Sell | 8112025 | 40.16 | 2,500 | 100,394 | 749,098 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.